Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a

Status Terminated

Clinical Trial Summary

Data from 15 healthy subjects will be recorded in two testing sessions spread on two days, using three lens designs (A, B and C). Before the measuring days, each subject will undergo an extra fitting session of a large-diameter scleral contact lens on the dominant eye, assessed by an experienced practitioner. The fitting data will be used to custom-make the three lens designs for each subject, thus ensuring their comfort and safety during the days of the experiments. During the experiment days baseline measurements will be obtained before and after pupil dilation and contact lens wear. During the first testing session data from the lens design A (reference lens without artificial iris) will be recorded. During the second testing session data from the lens designs B and C (lenses with artificial iris with different transmittances) will be recorded. In each testing session, contrast sensitivity and visual acuity will be evaluated and non-invasive imaging measurements will be undertaken (optical coherence tomography and slit lamp). A specific questionnaire will be given to the subject to assess comfort, light sensitivity, the horizontal visual angle and overall experience of the scleral lens and in combination with a pair of sunglasses category 3-4.

Clinical Trial Description

First, the participant will be subjected to an RGP scleral contact lens fitting session, then during the second and third visits the participant will be subjected to several non-invasive procedures specific to the study in order to assess contrast sensitivity and visual acuity using the fitted and uniquely fabricated investigational medical devices. The tests will be performed after eye drops are supplied to dilate the pupil of the subjects (eye drops: tropicamide and phenylephrine). Besides the clinical experiments, the participant will be given a specific questionnaire in order to assess comfort, light sensitivity, horizontal visual angle and overall experience of the investigational medical device and in combination with a pair of sunglasses category 3-4. The investigators will document the occurrence of any adverse events and specific side effects during Day 2 and 3 (testing sessions with the investigational devices) in order to effectively assess their safety. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04040790
Study type	Interventional
Source	University Ghent
Contact
Status	Terminated
Phase	N/A
Start date	September 16, 2019
Completion date	June 22, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04929756` - Eye Movement Rehabilitation in Low Vision Patients
Completed	`NCT04974307` - Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision	N/A
Completed	`NCT02310880` - Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World	N/A
Recruiting	`NCT06107881` - Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision	N/A
Completed	`NCT00545220` - Problem Solving Training and Low Vision Rehabilitation	N/A
Recruiting	`NCT04066075` - Beacon Sensors and Telerehabilitation for Low Vision	N/A
Recruiting	`NCT04281732` - Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
Completed	`NCT01217502` - Self-management for Dual Sensory Impaired	N/A
Completed	`NCT00946062` - Evaluation of a Standardised Orientation and Mobility Training in Older Adults With Low Vision	N/A
Terminated	`NCT04276610` - Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning?	N/A
Recruiting	`NCT05829135` - Improving Glare and Visual Comfort for Patients With Visual Impairment	N/A
Completed	`NCT04242836` - Development and Validation of a Digital Optotype for Near Vision in Greek Language.
Terminated	`NCT03353727` - Orthoptic Rehabilitation for Low Vision People With Innovative Mechanisms (Eye Tracker and Tactile Device)	N/A
Completed	`NCT04926974` - Community Access Through Remote Eyesight (CARE) Study	N/A
Completed	`NCT00348621` - A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents	Phase 4
Not yet recruiting	`NCT03104608` - Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD)	N/A
Completed	`NCT05491746` - Diabetic Retinopathy Tethered Augmented Reality With Eye4 Study	N/A
Completed	`NCT03728660` - Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System	N/A
Completed	`NCT05209581` - Assessment of Visual Acuity in Refugee Population
Recruiting	`NCT01879501` - Living Successfully With Chronic Eye Diseases	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris — RGPIRIS_PA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms